TBL1XR1 mutations in Pierpont syndrome are not restricted to the recurrent p.Tyr446Cys mutation

Pierpont syndrome is a rare and sporadic syndrome, including developmental delay, facial characteristics, and abnormal extremities. Recently, a recurrent de novo TBL1XR1 variant (c.1337A > G; p.Tyr446Cys) has been identified in eight patients by whole‐exome sequencing. A dominant‐negative effect...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of medical genetics. Part A 2018-12, Vol.176 (12), p.2813-2818
Hauptverfasser: Lemattre, C., Thevenon, J., Duffourd, Y., Nambot, S., Haquet, E., Vuadelle, B., Genevieve, D., Sarda, P., Bruel, A. L., Kuentz, P., Wells, C. F., Faivre, L., Willems, M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2818
container_issue 12
container_start_page 2813
container_title American journal of medical genetics. Part A
container_volume 176
creator Lemattre, C.
Thevenon, J.
Duffourd, Y.
Nambot, S.
Haquet, E.
Vuadelle, B.
Genevieve, D.
Sarda, P.
Bruel, A. L.
Kuentz, P.
Wells, C. F.
Faivre, L.
Willems, M.
description Pierpont syndrome is a rare and sporadic syndrome, including developmental delay, facial characteristics, and abnormal extremities. Recently, a recurrent de novo TBL1XR1 variant (c.1337A > G; p.Tyr446Cys) has been identified in eight patients by whole‐exome sequencing. A dominant‐negative effect of this mutation is strongly suspected, since patients with TBL1XR1 deletion and other variants predicting loss of function do not share the same phenotype. We report two patients with typical Pierpont‐like syndrome features. Exome sequencing allowed identifying a de novo heterozygous missense TBL1XR1 variant in both patients, different from those already reported: p.Cys325Tyr and p.Tyr446His. The localization of these mutations and clinical features of Pierpont‐like syndrome suggest that their functional consequences are comparable with the recurrent mutation previously described, and provided additional data to understand molecular mechanisms of TBL1XR1 anomalies.
doi_str_mv 10.1002/ajmg.a.40510
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_01915588v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2126901522</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3980-4c37ad411456078841076060f4d32bae9531287f9d257ee8fe4e084ecaac289d3</originalsourceid><addsrcrecordid>eNp90c9P2zAUB3ALbQLGuO08Wdplk2h5_hnn2FUDhoqYUJG4WSZ5GamSuLOTTfnvcRfWww6cbD199JWfv4R8YDBnAPzcbdqfczeXoBgckGOmFJ9JI8Sb_Z2rI_Iuxg2AAJXpQ3IkQGhlMnlM7Prrij3cMdoOvetr30Vad_RHjWHru57GsSuDb5G6gLTzPQ0Y-1AXPZa097R_wjQphhAw4e18PQYp9XKM-7j35G3lmoinL-cJub_4tl5ezVa3l9-Xi9WsELmBmSxE5krJmFQaMmMkg0yDhkqWgj86zJVg3GRVXnKVIZoKJYKRWDhXcJOX4oR8mXKfXGO3oW5dGK13tb1arOxuBixP32HMb5bs58lug_81pIVsW8cCm8Z16IdoOeM6B6Y4T_TTf3Tjh9ClTZLSLNOGSZnU2aSK4GMMWO1fwMDuSrK7kqyzf0tK_ONL6PDYYrnH_1pJQE7gT93g-GqYXVzfXC6m3GcQVpsV</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2161768144</pqid></control><display><type>article</type><title>TBL1XR1 mutations in Pierpont syndrome are not restricted to the recurrent p.Tyr446Cys mutation</title><source>Wiley Online Library All Journals</source><creator>Lemattre, C. ; Thevenon, J. ; Duffourd, Y. ; Nambot, S. ; Haquet, E. ; Vuadelle, B. ; Genevieve, D. ; Sarda, P. ; Bruel, A. L. ; Kuentz, P. ; Wells, C. F. ; Faivre, L. ; Willems, M.</creator><creatorcontrib>Lemattre, C. ; Thevenon, J. ; Duffourd, Y. ; Nambot, S. ; Haquet, E. ; Vuadelle, B. ; Genevieve, D. ; Sarda, P. ; Bruel, A. L. ; Kuentz, P. ; Wells, C. F. ; Faivre, L. ; Willems, M.</creatorcontrib><description>Pierpont syndrome is a rare and sporadic syndrome, including developmental delay, facial characteristics, and abnormal extremities. Recently, a recurrent de novo TBL1XR1 variant (c.1337A &gt; G; p.Tyr446Cys) has been identified in eight patients by whole‐exome sequencing. A dominant‐negative effect of this mutation is strongly suspected, since patients with TBL1XR1 deletion and other variants predicting loss of function do not share the same phenotype. We report two patients with typical Pierpont‐like syndrome features. Exome sequencing allowed identifying a de novo heterozygous missense TBL1XR1 variant in both patients, different from those already reported: p.Cys325Tyr and p.Tyr446His. The localization of these mutations and clinical features of Pierpont‐like syndrome suggest that their functional consequences are comparable with the recurrent mutation previously described, and provided additional data to understand molecular mechanisms of TBL1XR1 anomalies.</description><identifier>ISSN: 1552-4825</identifier><identifier>EISSN: 1552-4833</identifier><identifier>DOI: 10.1002/ajmg.a.40510</identifier><identifier>PMID: 30365874</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Gene deletion ; Genetics ; Life Sciences ; Localization ; Molecular modelling ; Mutation ; Phenotypes ; Pierpont syndrome ; TBL1XR1</subject><ispartof>American journal of medical genetics. Part A, 2018-12, Vol.176 (12), p.2813-2818</ispartof><rights>2018 Wiley Periodicals, Inc.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3980-4c37ad411456078841076060f4d32bae9531287f9d257ee8fe4e084ecaac289d3</citedby><cites>FETCH-LOGICAL-c3980-4c37ad411456078841076060f4d32bae9531287f9d257ee8fe4e084ecaac289d3</cites><orcidid>0000-0001-9770-444X ; 0000-0003-2814-6303 ; 0000-0002-2959-0935 ; 0000-0001-6928-6287</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajmg.a.40510$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajmg.a.40510$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30365874$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://u-bourgogne.hal.science/hal-01915588$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Lemattre, C.</creatorcontrib><creatorcontrib>Thevenon, J.</creatorcontrib><creatorcontrib>Duffourd, Y.</creatorcontrib><creatorcontrib>Nambot, S.</creatorcontrib><creatorcontrib>Haquet, E.</creatorcontrib><creatorcontrib>Vuadelle, B.</creatorcontrib><creatorcontrib>Genevieve, D.</creatorcontrib><creatorcontrib>Sarda, P.</creatorcontrib><creatorcontrib>Bruel, A. L.</creatorcontrib><creatorcontrib>Kuentz, P.</creatorcontrib><creatorcontrib>Wells, C. F.</creatorcontrib><creatorcontrib>Faivre, L.</creatorcontrib><creatorcontrib>Willems, M.</creatorcontrib><title>TBL1XR1 mutations in Pierpont syndrome are not restricted to the recurrent p.Tyr446Cys mutation</title><title>American journal of medical genetics. Part A</title><addtitle>Am J Med Genet A</addtitle><description>Pierpont syndrome is a rare and sporadic syndrome, including developmental delay, facial characteristics, and abnormal extremities. Recently, a recurrent de novo TBL1XR1 variant (c.1337A &gt; G; p.Tyr446Cys) has been identified in eight patients by whole‐exome sequencing. A dominant‐negative effect of this mutation is strongly suspected, since patients with TBL1XR1 deletion and other variants predicting loss of function do not share the same phenotype. We report two patients with typical Pierpont‐like syndrome features. Exome sequencing allowed identifying a de novo heterozygous missense TBL1XR1 variant in both patients, different from those already reported: p.Cys325Tyr and p.Tyr446His. The localization of these mutations and clinical features of Pierpont‐like syndrome suggest that their functional consequences are comparable with the recurrent mutation previously described, and provided additional data to understand molecular mechanisms of TBL1XR1 anomalies.</description><subject>Gene deletion</subject><subject>Genetics</subject><subject>Life Sciences</subject><subject>Localization</subject><subject>Molecular modelling</subject><subject>Mutation</subject><subject>Phenotypes</subject><subject>Pierpont syndrome</subject><subject>TBL1XR1</subject><issn>1552-4825</issn><issn>1552-4833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp90c9P2zAUB3ALbQLGuO08Wdplk2h5_hnn2FUDhoqYUJG4WSZ5GamSuLOTTfnvcRfWww6cbD199JWfv4R8YDBnAPzcbdqfczeXoBgckGOmFJ9JI8Sb_Z2rI_Iuxg2AAJXpQ3IkQGhlMnlM7Prrij3cMdoOvetr30Vad_RHjWHru57GsSuDb5G6gLTzPQ0Y-1AXPZa097R_wjQphhAw4e18PQYp9XKM-7j35G3lmoinL-cJub_4tl5ezVa3l9-Xi9WsELmBmSxE5krJmFQaMmMkg0yDhkqWgj86zJVg3GRVXnKVIZoKJYKRWDhXcJOX4oR8mXKfXGO3oW5dGK13tb1arOxuBixP32HMb5bs58lug_81pIVsW8cCm8Z16IdoOeM6B6Y4T_TTf3Tjh9ClTZLSLNOGSZnU2aSK4GMMWO1fwMDuSrK7kqyzf0tK_ONL6PDYYrnH_1pJQE7gT93g-GqYXVzfXC6m3GcQVpsV</recordid><startdate>201812</startdate><enddate>201812</enddate><creator>Lemattre, C.</creator><creator>Thevenon, J.</creator><creator>Duffourd, Y.</creator><creator>Nambot, S.</creator><creator>Haquet, E.</creator><creator>Vuadelle, B.</creator><creator>Genevieve, D.</creator><creator>Sarda, P.</creator><creator>Bruel, A. L.</creator><creator>Kuentz, P.</creator><creator>Wells, C. F.</creator><creator>Faivre, L.</creator><creator>Willems, M.</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><general>Wiley</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0001-9770-444X</orcidid><orcidid>https://orcid.org/0000-0003-2814-6303</orcidid><orcidid>https://orcid.org/0000-0002-2959-0935</orcidid><orcidid>https://orcid.org/0000-0001-6928-6287</orcidid></search><sort><creationdate>201812</creationdate><title>TBL1XR1 mutations in Pierpont syndrome are not restricted to the recurrent p.Tyr446Cys mutation</title><author>Lemattre, C. ; Thevenon, J. ; Duffourd, Y. ; Nambot, S. ; Haquet, E. ; Vuadelle, B. ; Genevieve, D. ; Sarda, P. ; Bruel, A. L. ; Kuentz, P. ; Wells, C. F. ; Faivre, L. ; Willems, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3980-4c37ad411456078841076060f4d32bae9531287f9d257ee8fe4e084ecaac289d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Gene deletion</topic><topic>Genetics</topic><topic>Life Sciences</topic><topic>Localization</topic><topic>Molecular modelling</topic><topic>Mutation</topic><topic>Phenotypes</topic><topic>Pierpont syndrome</topic><topic>TBL1XR1</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lemattre, C.</creatorcontrib><creatorcontrib>Thevenon, J.</creatorcontrib><creatorcontrib>Duffourd, Y.</creatorcontrib><creatorcontrib>Nambot, S.</creatorcontrib><creatorcontrib>Haquet, E.</creatorcontrib><creatorcontrib>Vuadelle, B.</creatorcontrib><creatorcontrib>Genevieve, D.</creatorcontrib><creatorcontrib>Sarda, P.</creatorcontrib><creatorcontrib>Bruel, A. L.</creatorcontrib><creatorcontrib>Kuentz, P.</creatorcontrib><creatorcontrib>Wells, C. F.</creatorcontrib><creatorcontrib>Faivre, L.</creatorcontrib><creatorcontrib>Willems, M.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>American journal of medical genetics. Part A</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lemattre, C.</au><au>Thevenon, J.</au><au>Duffourd, Y.</au><au>Nambot, S.</au><au>Haquet, E.</au><au>Vuadelle, B.</au><au>Genevieve, D.</au><au>Sarda, P.</au><au>Bruel, A. L.</au><au>Kuentz, P.</au><au>Wells, C. F.</au><au>Faivre, L.</au><au>Willems, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TBL1XR1 mutations in Pierpont syndrome are not restricted to the recurrent p.Tyr446Cys mutation</atitle><jtitle>American journal of medical genetics. Part A</jtitle><addtitle>Am J Med Genet A</addtitle><date>2018-12</date><risdate>2018</risdate><volume>176</volume><issue>12</issue><spage>2813</spage><epage>2818</epage><pages>2813-2818</pages><issn>1552-4825</issn><eissn>1552-4833</eissn><abstract>Pierpont syndrome is a rare and sporadic syndrome, including developmental delay, facial characteristics, and abnormal extremities. Recently, a recurrent de novo TBL1XR1 variant (c.1337A &gt; G; p.Tyr446Cys) has been identified in eight patients by whole‐exome sequencing. A dominant‐negative effect of this mutation is strongly suspected, since patients with TBL1XR1 deletion and other variants predicting loss of function do not share the same phenotype. We report two patients with typical Pierpont‐like syndrome features. Exome sequencing allowed identifying a de novo heterozygous missense TBL1XR1 variant in both patients, different from those already reported: p.Cys325Tyr and p.Tyr446His. The localization of these mutations and clinical features of Pierpont‐like syndrome suggest that their functional consequences are comparable with the recurrent mutation previously described, and provided additional data to understand molecular mechanisms of TBL1XR1 anomalies.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>30365874</pmid><doi>10.1002/ajmg.a.40510</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-9770-444X</orcidid><orcidid>https://orcid.org/0000-0003-2814-6303</orcidid><orcidid>https://orcid.org/0000-0002-2959-0935</orcidid><orcidid>https://orcid.org/0000-0001-6928-6287</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1552-4825
ispartof American journal of medical genetics. Part A, 2018-12, Vol.176 (12), p.2813-2818
issn 1552-4825
1552-4833
language eng
recordid cdi_hal_primary_oai_HAL_hal_01915588v1
source Wiley Online Library All Journals
subjects Gene deletion
Genetics
Life Sciences
Localization
Molecular modelling
Mutation
Phenotypes
Pierpont syndrome
TBL1XR1
title TBL1XR1 mutations in Pierpont syndrome are not restricted to the recurrent p.Tyr446Cys mutation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T03%3A42%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TBL1XR1%20mutations%20in%20Pierpont%20syndrome%20are%20not%20restricted%20to%20the%20recurrent%20p.Tyr446Cys%20mutation&rft.jtitle=American%20journal%20of%20medical%20genetics.%20Part%20A&rft.au=Lemattre,%20C.&rft.date=2018-12&rft.volume=176&rft.issue=12&rft.spage=2813&rft.epage=2818&rft.pages=2813-2818&rft.issn=1552-4825&rft.eissn=1552-4833&rft_id=info:doi/10.1002/ajmg.a.40510&rft_dat=%3Cproquest_hal_p%3E2126901522%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2161768144&rft_id=info:pmid/30365874&rfr_iscdi=true